drugset / Trial / NCT01974167
Eldecalcitol for GLucocorticoid Induced OsteopoRosIs Versus Alfacalcidol
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of eldecalcitol monotherapy compared with alfacalcidol monotherapy in patients with glucocorticoid-induced osteoporosis, using a randomized, open-label, parallel-group, comparative design.
Timeline
- Start
- 2013-12
- Primary completion
- 2018-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alfacalcidol | Other / unclassified | 1 ug | Oral |
| Subject | Eldecalcitol | Small molecule | 0.75 ug | Oral |